Cargando…

Synthesized HMGB1 peptide attenuates liver inflammation and suppresses fibrosis in mice

The liver has a high regenerative ability and can induce spontaneous regression of fibrosis when early liver damage occurs; however, these abilities are lost when chronic liver damage results in decompensated cirrhosis. Cell therapies, such as mesenchymal stem cell (MSC) and macrophage therapies, ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nojiri, Shunsuke, Tsuchiya, Atsunori, Natsui, Kazuki, Takeuchi, Suguru, Watanabe, Takayuki, Kojima, Yuichi, Watanabe, Yusuke, Kamimura, Hiroteru, Ogawa, Masahiro, Motegi, Satoko, Iwasawa, Takahiro, Sato, Takeki, Kumagai, Masaru, Ishii, Yui, Kitayama, Tomomi, Li, Yu-Tung, Ouchi, Yuya, Shimbo, Takashi, Takamura, Masaaki, Tamai, Katsuto, Terai, Shuji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474861/ https://www.ncbi.nlm.nih.gov/pubmed/34565478 http://dx.doi.org/10.1186/s41232-021-00177-4

Ejemplares similares

Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases
por: Tsuchiya, Atsunori, et al.
Publicado: (2020)

A novel prostaglandin I(2) agonist, ONO-1301, attenuates liver inflammation and suppresses fibrosis in non-alcoholic steatohepatitis model mice
por: Motegi, Satoko, et al.
Publicado: (2022)

Combination therapy of Juzentaihoto and mesenchymal stem cells attenuates liver damage and regresses fibrosis in mice
por: Iwasawa, Takahiro, et al.
Publicado: (2021)

Molecular Mechanisms and Treatment of Sarcopenia in Liver Disease: A Review of Current Knowledge
por: Kamimura, Hiroteru, et al.
Publicado: (2021)

A Case of Hepatorenal Syndrome and Abdominal Compartment Syndrome with High Renal Congestion
por: Kamimura, Hiroteru, et al.
Publicado: (2017)

Novel Strategy for Diagnosis of Focal Nodular Hyperplasia Using Gadolinium Ethoxybenzyl Diethylenetriaminepentaacetic Acid: Enhanced Magnetic Resonance Imaging and Magnetic Resonance Elastography
por: Takeda, Nobutaka, et al.
Publicado: (2021)

Bleeding from a Small-Intestinal Ulcer Associated with Chronic Hepatitis C
por: Kamimura, Hiroteru, et al.
Publicado: (2018)

Renal Impairment in Chronic Hepatitis B: A Review
por: Kamimura, Hiroteru, et al.
Publicado: (2018)

Long-term efficacy and safety of nalfurafine hydrochloride on pruritus in chronic liver disease patients: Patient-reported outcome based analyses
por: Kamimura, Kenya, et al.
Publicado: (2017)

Mesenchymal stem cell therapies for liver cirrhosis: MSCs as “conducting cells” for improvement of liver fibrosis and regeneration
por: Tsuchiya, Atsunori, et al.
Publicado: (2019)

Mesenchymal stem cells cultured under hypoxic conditions had a greater therapeutic effect on mice with liver cirrhosis compared to those cultured under normal oxygen conditions
por: Kojima, Yuichi, et al.
Publicado: (2019)

Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies
por: Kobayashi, Takamasa, et al.
Publicado: (2018)

Prognostic value of subcutaneous adipose tissue volume in hepatocellular carcinoma treated with transcatheter intra-arterial therapy
por: Kobayashi, Takamasa, et al.
Publicado: (2018)

Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: a randomized controlled trial
por: Kamimura, Kenya, et al.
Publicado: (2017)

Development of a non-alcoholic steatohepatitis model with rapid accumulation of fibrosis, and its treatment using mesenchymal stem cells and their small extracellular vesicles
por: Watanabe, Takayuki, et al.
Publicado: (2020)

Refractory hemorrhagic esophageal ulcers by Candida esophagitis with advanced systemic sclerosis
por: Natsui, Kazuki, et al.
Publicado: (2020)

Use of a Deep Learning Approach for the Sensitive Prediction of Hepatitis B Surface Antigen Levels in Inactive Carrier Patients
por: Kamimura, Hiroteru, et al.
Publicado: (2022)

PDGFRα‐lineage origin directs monocytes to trafficking proficiency to support peripheral immunity
por: Li, Yu‐Tung, et al.
Publicado: (2021)

Transition of clinical and basic studies on liver cirrhosis treatment using cells to seek the best treatment
por: Terai, Shuji, et al.
Publicado: (2021)

Machine learning prediction model for treatment responders in patients with primary biliary cholangitis
por: Kimura, Naruhiro, et al.
Publicado: (2023)

Antiprogramed cell death‐1 therapy with microspheres for metastatic liver tumors
por: Kamimura, Hiroteru, et al.
Publicado: (2019)

Rational arrangement of measuring shear wave speed in the liver
por: Yokoo, Takeshi, et al.
Publicado: (2019)

Lusutrombopag increases hematocytes in a compensated liver cirrhosis patient
por: Sakamaki, Akira, et al.
Publicado: (2017)

Longitudinal Single-Cell Transcriptomics Reveals a Role for Serpina3n-Mediated Resolution of Inflammation in a Mouse Colitis Model
por: Ho, Yen-Ting, et al.
Publicado: (2021)

Effects of Human Adipose Tissue-Derived and Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in a Dextran Sulfate Sodium-Induced Mouse Model
por: Ikarashi, Shunzo, et al.
Publicado: (2019)

Single-cell transcriptome analysis of a rat model of bilateral renal ischemia-reperfusion injury
por: Taniguchi, Ayumu, et al.
Publicado: (2023)

Longitudinal increase in albumin–bilirubin score is associated with non-malignancy-related mortality and quality of life in patients with liver cirrhosis
por: Sakamaki, Akira, et al.
Publicado: (2022)

Single-cell transcriptome analysis reveals cellular heterogeneity in mouse intra- and extra articular ligaments
por: Ishibashi, Kyota, et al.
Publicado: (2022)

Considerations of elderly factors to manage the complication of liver cirrhosis in elderly patients
por: Kamimura, Kenya, et al.
Publicado: (2019)

Diverse perspectives to address for the future treatment of heterogeneous hepatocellular carcinoma
por: Tsuchiya, Atsunori, et al.
Publicado: (2019)

Benign Duodenal Stenosis Caused by Huge Mesenteric Hematoma Conservatively Improved with Long-term Use of Double Elementary Diet Tube
por: Setsu, Toru, et al.
Publicado: (2021)

Small extracellular vesicles and liver diseases: From diagnosis to therapy
por: Tsuchiya, Atsunori, et al.
Publicado: (2022)

Small extracellular vesicles derived from interferon-γ pre-conditioned mesenchymal stromal cells effectively treat liver fibrosis
por: Takeuchi, Suguru, et al.
Publicado: (2021)

Small Intestinal Bacterial Overgrowth Diagnosed by a Breath Test and Improved by Rifaximin in a Patient with Hepatic Encephalopathy and Alcoholic Liver Cirrhosis
por: Sakamaki, Akira, et al.
Publicado: (2020)

Rare case of circumferential esophageal peeling
por: Tominaga, Kentaro, et al.
Publicado: (2020)

The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future
por: Watanabe, Yusuke, et al.
Publicado: (2021)

Potential Effect of a Selective Peroxisome Proliferator-activated Receptor Alpha Modulator on Metabolic Dysfunction-associated Fatty Liver Disease
por: Kamimura, Hiroteru, et al.
Publicado: (2021)

Spontaneous regression of hepatocellular carcinoma: A mini-review
por: Sakamaki, Akira, et al.
Publicado: (2017)

Rare complication of hepatocellular carcinoma in Wilson's disease
por: Ohkoshi‐Yamada, Marina, et al.
Publicado: (2021)

Clinical trials using mesenchymal stem cells in liver diseases and inflammatory bowel diseases
por: Tsuchiya, Atsunori, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4pcreulcvqo7cpue3dni55d93r